GOG-3066 ZN-c3-005 platinum resistant ovarian cancer - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Subjects with High-Grade Serous Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer
Principal Investigator
Gynecologic Oncologist
Protocol Number
IRB:
PRO00110517
NCT:
NCT05128825
Phase
Phase
II
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment